A DESCRIPTIVE ANALYSIS OF COSTS AND HEALTHCARE RESOURCE USE IN PATIENTS WITH BRONCHIOLITIS OBLITERANS SYNDROME (BOS) FOLLOWING LUNG TRANSPLANTATION

被引：0
|
作者：
Sacks, N. [1 ]
Sheshadri, A. [2 ]
Healey, B. [3 ]
Raza, S. [3 ]
Cyr, P. L. [3 ]
Boerner, G. [4 ]
Huang, H. [5 ]
机构：
[1] Milestone Pharmaceut Inc, Boston, MA USA
[2] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[3] Precis Hlth Econ & Outcomes Res, Boston, MA USA
[4] Breath Therapeut GmbH, Munich, Germany
[5] Houston Methodist Hosp, Houston, TX 77030 USA
来源：
VALUE IN HEALTH | 2021年 / 24卷
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PMU10
引用
下载
收藏
页码：S146 / S147
页数：2
相关论文
共 50 条
  • [21] Update on Bronchiolitis Obliterans Syndrome in Lung Transplantation
    Lin C.M.
    Zamora M.R.
    Current Transplantation Reports, 2014, 1 (4) : 282 - 289
  • [22] A Randomised Controlled Trial of Azithromycin Therapy in Bronchiolitis Obliterans Syndrome (BOS) Post Lung Transplantation
    Corris, P. A.
    Small, T.
    Ryan, V. A.
    Lordan, J.
    Fisher, A. J.
    Meachery, G.
    Johnson, G.
    Ward, C.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2012, 31 (04): : S67 - S67
  • [23] Bronchiolitis Obliterans Following Lung Transplantation and Stem Cell Transplantation in Pediatric Patients
    Strawbridge, Heather D.
    Spahr, Jonathan E.
    Galambos, Csaba
    Kurland, Geoffrey
    CURRENT PEDIATRIC REVIEWS, 2010, 6 (03) : 192 - 203
  • [24] THE LEUVEN EXPERIENCE WITH A DICHOTOMY IN BRONCHIOLITIS OBLITERANS SYNDROME (BOS) AFTER LUNG TRANSPLANTATION REVEALED BY AZITHROMYCIN
    Vanaudenaerde, Bart
    Vos, Robin
    Geudens, Nele
    Van Raemdonck, Dirk
    Dupont, Lieven
    Verleden, Geert
    EUROPEAN RESPIRATORY REVIEW, 2008, 17 (108): : 93 - 95
  • [25] Serum IgA Deficiency Is Common in Lung Transplantation and Is Independently Associated with Bronchiolitis Obliterans Syndrome (BOS)
    Chambers, D. C.
    Davies, B.
    Yerkovich, S.
    Hopkins, P. M.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2010, 29 (02): : S118 - S119
  • [26] A randomised controlled trial of azithromycin therapy in bronchiolitis obliterans syndrome (BOS) post lung transplantation
    Corris, Paul A.
    Ryan, Victoria A.
    Small, Therese
    Lordan, James
    Fisher, Andrew J.
    Meachery, Gerard
    Johnson, Gail
    Ward, Chris
    THORAX, 2015, 70 (05) : 442 - U150
  • [27] The Lower Airway Bacterial Microbiota In Patients With And Without Bronchiolitis Obliterans Syndrome Following Lung Transplantation
    Rogers, G.
    Van Der Gast, C.
    Hopkins, P.
    Yerkovich, S.
    Bruce, K.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 187
  • [28] Post hoc analysis of a randomized trial of azithromycin in bronchiolitis obliterans syndrome after Lung transplantation (BOS); Lung function and survival
    Gan, Tji
    Ward, Chris
    Lordan, Jim
    Meachery, Gerry
    Fisher, Andy
    Corris, Paul
    EUROPEAN RESPIRATORY JOURNAL, 2017, 50
  • [29] Stochastic modelling of the onset of bronchiolitis obliterans syndrome following lung transplantation:: An analysis of risk factors
    Faddy, MJ
    Taylor, GJ
    MATHEMATICAL AND COMPUTER MODELLING, 2003, 38 (11-13) : 1185 - 1189
  • [30] Extracorporal photopheresis has an impact on several lymphocyte subpopulations in patients with bronchiolitis obliterans syndrome (BOS) after lung transplantation
    Schmitt, A.
    Lorenz, K.
    Rommel, K.
    Mani, J.
    Hilgendorf, I
    Freund, M.
    Schmitt, M.
    ONKOLOGIE, 2012, 35 : 62 - 62
12345